Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

NPCE stock hub

NeuroPace, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NPCEis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

623M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

NPCE

In the news

Latest news · NPCE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-158.7

P25 -105.6P50 -46.5P75 -3.1

ROIC-11.9

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NPCE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

211

Groups with data

Currency

USD

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001528287
Company name	NeuroPace, Inc.
Country	United States
Country code	US
Cusip	641288105
Employees	209
Employees Change	25%
Employees Change Percent	13.59
Enterprise value	$632.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
IPO Date	2021-04-22
Isin	US6412881053
Last refreshed	2026-05-10
Market cap	$623M
Market cap category	Small-Cap
Price	$18.35
Price currency	USD
Rev Per Employee	478,401.91x
Sector	Healthcare
Sic	3841
Symbol	NPCE
Website	https://www.neuropace.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.45%
EV Sales Forward	6.27x
EV/Sales	6.33x
FCF yield	-1.82%
P/B ratio	32.37x
P/S ratio	6.23x
PS Forward	6.17x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-16.34%
EBITDA Margin	-16.1%
Gross margin	77.23%
Gross Profit	$77.2M
Gross Profit Growth	30.69%
Gross Profit Growth Q	27.12%
Gross Profit Growth3 Y	33.45%
Gross Profit Growth5 Y	20.6%
Net Income	$-21.5M
Net Income Growth Quarters	2%
Net Income Growth Years	3%
Pretax Margin	-21.47%
Profit Margin	-21.47%
Profit Per Employee	$-102,703
ROA	-10.2
Roa5y	-15.03
ROCE	-18.62
ROE	-158.7
Roe5y	-132.2
ROIC	-11.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	51.45%
Cagr3y	54.75%
Cagr5y	-2.8%
EPS Growth Quarters	2
EPS Growth Years	6
Revenue Growth	25.13x
Revenue Growth Q	23.86x
Revenue Growth Quarters	14x
Revenue Growth Years	6x
Revenue Growth3 Y	29.99x
Revenue Growth5 Y	19.44x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1
Assets	$105.6M
Cash	$61.1M
Current Assets	$94.1M
Current Liabilities	$17.8M
Debt	$70.8M
Debt Equity	$3.72
Equity	$19M
Interest Coverage	-2.19
Liabilities	$86.5M
Long Term Assets	$11.5M
Long Term Liabilities	$68.7M
Net Cash	$-9.8M
Net Cash By Market Cap	$-1.57
Net Debt Equity	$0.51
Tangible Book Value	$19M
Tangible Book Value Per Share	$0.57
WACC	14.19

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.28
Inventory Turnover	1.5
Net Working Capital	$17.3M
Quick ratio	4.25
Working Capital	$76.3M
Working Capital Turnover	$1.4

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-12.35%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	51.4%
200-day SMA	13.28
3Y total return	270.71%
50-day SMA	15.06
50-day SMA vs 200-day SMA	50over200
5Y total return	-13.24%
All Time High	27.38
All Time High Change	-32.98%
All Time High Date	2021-04-27
All Time Low	1.22
All Time Low Change	1,404.1%
All Time Low Date	2022-12-28
ATR	0.87
Beta	1.93
Beta1y	1.41
Beta2y	0.61
Ch YTD	18.85
High	19.6
High52	19.6
High52 Date	2026-05-08
High52ch	-6.38%
Low	18.32
Low52	7.56
Low52 Date	2025-08-13
Low52ch	142.63%
Ma50ch	21.85%
Premarket Change Percent	2.13
Premarket Price	$19.7
Premarket Volume	1,090
Price vs 200-day SMA	38.21%
RSI	66.21
RSI Monthly	63
RSI Weekly	68.12
Sharpe ratio	0.88x
Sortino ratio	1.58
Total Return	-12.35%
Tr YTD	18.85
Tr1m	26.47%
Tr1w	7.5%
Tr3m	17.1%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.22
Earnings Revenue Estimate	21,644,224x
Earnings Revenue Estimate Growth	-3.91x
Operating Income	$-16.3M
Operating margin	-16.34
Price target	$18.33
Price Target Change	$-0.11

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	23,137,707%
Float Percent	68.15%
Net Borrowing	-2,072,000
Shares Insiders	3.74%
Shares Institutions	65.76%
Shares Out	33,950,449
Shares Qo Q	0.76%
Shares Yo Y	12.35%
Short Float	3.96%
Short Ratio	4.88
Short Shares	2.7

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-22.4M
Average Volume	187,258.45x
Bv Per Share	0.57
CAPEX	$-332,000
Ch1m	26.47
Ch1w	7.5
Ch1y	51.4
Ch3m	17.1
Ch3y	270.7
Ch5y	-13.24
Ch6m	39.86
Change	-4.87%
Change From Open	-5.9
Close	19.29
Days Gap	1.09
Depreciation Amortization	238,000
Dollar Volume	6,039,223.6
Earnings Date	2026-05-12
Earnings Time	amc
EBIT	$-16.3M
EBITDA	$-16.1M
EPS	$-0.66
F Score	4
FCF	$-11.3M
FCF EV Yield	-1.79x
FCF Per Share	$-0.33
Financing CF	19,600,000
Fiscal Year End	December
Founded	1,997
Investing CF	-332,000
Ipr	7.94
Iprfo	-21.08
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-03
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-03
Ma150	14.58
Ma150ch	25.84%
Ma20	16.77
Ma20ch	9.43%
Net CF	8,262,000
Next Earnings Date	2026-05-12
Open	19.5
Optionable	Yes
Position In Range	2.34
Post Close	18.35
Postmarket Change Percent	0.11
Postmarket Price	$18.37
Ppne	11,257,000
Pre Close	19.29
Price Date	2026-05-08
Ptbv Ratio	32.74
Relative Volume	1.76x
Revenue	99,986,000x
SBC By Revenue	11.09x
Share Based Comp	11,089,000
Tr6m	39.86%
Us State	California
Volume	329,113
Z Score	-3.33

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NPCE pay a dividend?

Capital-return profile for this ticker.

Performance

NPCE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NPCE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+65.8%

Float: +68.2% of shares outstanding

Insider ownership

+3.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

NPCE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

66.2

Neutral momentum band

Price vs 200-day MA

+38.2%

50/200-day relationship not available

Beta (5Y)

1.93

More volatile than the market

Sharpe ratio

0.88

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NPCE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current NPCE stock rating?

NeuroPace, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full NPCE analysis?

The full report lives at /stocks/NPCE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for NPCE?

The latest report frames NPCE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the NPCE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.